Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

sheeba farhat

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at editorial@medicaldialogues.in.

Home

sheeba farhat

Articles By : sheeba farhat

Hetero Launches Generic Semaglutide Brands Truglyx, Rolmodl, Moto G Across 75+ Countries

sheeba farhat28 March 2026 8:22 PM IST

New Delhi: Hetero has announced the export launch of its generic semaglutide portfolio, marking a significant step toward expanding access to GLP-1...

Biocon Appoints Shreehas Tambe as CEO and MD, Kedar Upadhye Named CFO Amid Business Integration

sheeba farhat28 March 2026 8:18 PM IST

Bengaluru: Biocon Limited today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1,...

AAP MP Flags Spurious Drugs Crisis, Seeks National Quality Authority as Paracetamol Fails CDSCO Tests

sheeba farhat28 March 2026 8:13 PM IST

New Delhi: AAP MP Vikramjit Singh Sahney on Friday raised the issue of spurious medicines and expressed serious concern over the rising threat of...

Setback to Wave Life Sciences: Obesity Drug WVE-007 Shows Limited Efficacy in Early Trial

sheeba farhat27 March 2026 11:05 PM IST

Bengaluru: Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement...

USFDA Approves Corcept Therapeutics' Ovarian Cancer Drug Lifyorli

sheeba farhat27 March 2026 10:54 PM IST

Bengaluru: Corcept Therapeutics shares jumped more than 23% to a near two-month high on Wednesday after the U.S. health regulator approved the...

Novo Slashes Wegovy Prices Amid Lilly's Mounjaro Surge in South African Market

sheeba farhat26 March 2026 11:24 PM IST

Johannesburg: Novo Nordisk is cutting South African prices of its weight-loss drug Wegovy for a second time since it launched in August, local...

UK MHRA to Allow Drug Reviews Without Animal Testing by 2026, Issues Draft Framework

sheeba farhat26 March 2026 11:19 PM IST

Bengaluru: Britain's medicines regulator said on Wednesday it will introduce a framework by the end of 2026, which would allow drugmakers to ask a...

Mercks Enlicitide Outperforms Rivals in Cutting Bad Cholesterol in Late-Stage Trial

Merck Nears USD 6 Billion Terns Pharma Deal Amid Keytruda Patent Expiry Push

sheeba farhat25 March 2026 11:18 PM IST

Mexico City: Pharmaceutical company Merck is nearing a roughly USD 6 billion all-cash deal to acquire biotech firm Terns Pharma, ‌the ⁠Financial...

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Pfizer, Valneva Lyme Disease Vaccine Shows Over 70% Efficacy in Late-Stage Trial

sheeba farhat25 March 2026 11:08 PM IST

Bengaluru: The U.S. drugmaker Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than 70% efficacy in a...

Gilead to Acquire Ouro Medicines in USD 2 Billion Deal to Boost Immunology Pipeline

sheeba farhat24 March 2026 10:15 AM IST

Bengaluru: Gilead Sciences said on Monday it would buy privately held biotech firm Ouro Medicines in a deal worth more than USD 2 billion to expand...

USFDA Flags Seizure Risk in Parkinson's Drugs, Orders Label Updates

sheeba farhat23 March 2026 11:45 AM IST

Bengaluru: The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain Parkinson's disease treatments to update...

Roche Drops Muscle Disease Drug After Trial Failure

sheeba farhat23 March 2026 11:30 AM IST

Bengaluru: Roche has stopped developing its experimental drug for two rare muscle diseases after it failed to show meaningful benefits, the Swiss...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok